Some studies have reported decreased CD34+/CD133+/VEGFR2+ cell counts in SSc by flow cytometry [14,15,21], whereas increased circulating EPC levels have been reported elsewhere [13,22,23]. This evidence concerns the gene KDR and systemic sclerosis.